SHAREHOLDERS' EQUITY (Details 1) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021
Number of Options outstanding
Beginning balance	6,204,605
Granted	406,575
Exercised	(2,693,614)
Expired and forfeited	(117,542)
Ending balance	3,800,024	6,204,605
Exercisable	2,126,460
Weighted-Average Exercise Price
Beginning balance	$ 13.53
Granted	192.91
Exercised	2.28
Expired and forfeited	48.88
Ending balance	39.6	$ 13.53
Exercisable	$ 19.4
Weighted Average Remaining Contractual life, Outstanding	7 years 5 months 15 days	7 years 2 months 15 days
Weighted Average Remaining Contractual life, Exercisable	6 years 10 months 9 days
Aggregate Intrinsic Value, outstanding	$ 347,627	$ 1,831,568
Aggregate Intrinsic Value, exercisable	$ 223,393

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.